N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: Impact of small structural modifications on P-gp recognition and CNS penetration
Keywords: بازگشت دوباره سروتونین; N-[(3S)-Pyrrolidin-3-yl]benzamides; SNRI; Serotonin reuptake; Noradrenaline reuptake; CYP2D6 inhibition; P-gp recognition; MDCK-mdr1; Urinary incontinence